Mumbai
08048034404
+918506873687

Liver Transplant & Advanced Hepatology – Authority FAQ Dr Chetan Kalal | Mumbai | International Consults



Liver Transplant & Advanced Hepatology – Authority FAQ

Dr Chetan Kalal | Mumbai | International Consults


1. When is a liver transplant actually necessary?

A liver transplant is necessary when liver failure becomes irreversible and life-threatening despite optimal medical therapy.

Common clinical triggers:

  • Decompensated cirrhosis (ascites, variceal bleeding, encephalopathy)

  • MELD score ≥15–18

  • Acute-on-chronic liver failure (ACLF)

  • Hepatocellular carcinoma within transplant criteria

  • Wilson disease with liver failure

  • Autoimmune hepatitis not responding to steroids

Transplant is based on mortality risk — not just symptoms.


2. What MELD score indicates need for liver transplant?

MELD (Model for End-Stage Liver Disease) predicts 3-month mortality.

General interpretation:

  • MELD <10 → Usually medical management

  • MELD 15–18 → Transplant evaluation recommended

  • MELD >25 → High short-term mortality risk

  • MELD >30 → Urgent transplant consideration

MELD-Na (including sodium) improves mortality prediction.

MELD is a survival prediction tool — not a comfort scale.


3. What is the survival rate after liver transplant?

In experienced programs:

  • 1-year survival: ~85–92%

  • 5-year survival: ~70–80%

Survival depends on:

  • Pre-transplant condition

  • ICU stability

  • Infection control

  • Donor quality

  • Post-transplant compliance

Early referral improves survival probability.


4. How long does liver transplant recovery take?

Typical recovery timeline:

  • ICU stay: 5–10 days (variable)

  • Total hospital stay: 2–3 weeks

  • Return to light activity: 6–8 weeks

  • Functional recovery: 3–6 months

Full metabolic stabilization may take up to 12 months.


5. Can fatty liver (MASLD/NASH) lead to transplant?

Yes.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of cirrhosis globally.

High-risk indicators:

  • Fibrosis stage F3–F4

  • Liver stiffness >12–14 kPa

  • Diabetes with elevated ALT

  • Progressive sarcopenia

Fatty liver becomes dangerous when fibrosis progresses.


6. Is living donor liver transplant safe?

Living donor liver transplant (LDLT) involves removing a portion of a healthy donor’s liver. The liver regenerates in both donor and recipient.

Donor safety requires:

  • Strict medical screening

  • Liver volumetry

  • Absence of significant steatosis

  • Independent ethics review

Donor mortality risk in experienced centers is low but not zero.
Informed consent is critical.


7. When should you seek a second opinion in liver disease?

You should seek a second opinion if:

  • You were advised “wait and watch” despite worsening labs

  • MELD is rising but transplant not discussed

  • Conflicting biopsy reports exist

  • You were denied transplant without clarity

  • Complex autoimmune or Wilson disease diagnosis

A proper second opinion provides staging, risk prediction, and defined next steps.


8. Can international patients undergo liver transplant in India?

Yes.

International patients often seek India for:

  • Living donor expertise

  • Reduced waiting time

  • Structured transplant programs

  • Cost transparency compared to US/UK systems

A structured pathway includes:

  • Pre-arrival documentation review

  • Eligibility confirmation

  • Donor-recipient parallel workup

  • Post-discharge remote monitoring

Medical leadership should guide relocation — not intermediaries.


9. What are warning signs of worsening liver failure?

Urgent red flags include:

  • Increasing abdominal swelling (ascites)

  • Recurrent vomiting blood

  • Confusion or drowsiness

  • Rapidly worsening jaundice

  • Kidney dysfunction

  • Severe muscle loss (sarcopenia)

These indicate high short-term mortality risk.


10. When is transplant not recommended?

Transplant may not be appropriate in:

  • Uncontrolled sepsis

  • Advanced multi-organ failure

  • Severe cardiopulmonary instability

  • Active substance abuse

  • Poor rehabilitation potential

Eligibility is individualized and ethically reviewed.



 2026-02-26T05:59:37

Other Pages

View all pages